Floatz logo

mln9708

Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)

Steven E. CoutrePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Alice Mims
Phase 3BBB
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 3BBB
Idarubicine
The First Affiliated Hospital of Soochow University
Phase 2BBB
Mitoxantrone
BGI, China
Phase 2BBB

View all 50 →

Same molecule, other indications

mln9708 is also rated in:

Multiple MyelomaDormant
BB
Indicative ·
66 / 100
View asset →
AmyloidosisDormant
BB
Indicative ·
64 / 100
View asset →
Higher-risk Myelodysplastic SyndromeDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →